344 <strong>Biomedical</strong> <strong>Engineering</strong> <strong>–</strong> <strong>From</strong> <strong>Theory</strong> <strong>to</strong> <strong>Applications</strong> Badger, J. (1989b). Circumcision. What you think. Australian Forum 2 (11), 10-29. Baeten, J.M., Donnell, D., Inambo, M., John-Stewart, G., Kapiga, S., Manongi, R., Ronald, A., Vwakila, B. & Celum, C. (2009). Male circumcision and risk of male-<strong>to</strong>-female HIV- 1 transmission: A multinational prospective study. 5th International AIDS Society Conference, Cape Town, South Africa, LBPEC06. Baeten, J.M., Donnell, D., Kapiga, S.H., Ronald, A., John-Stewart, G., Inambao, M., Manongi, R., Vwalika, B. & Celum, C. (2010). Male circumcision and risk of male-<strong>to</strong>-female HIV-1 transmission: a multinational prospective study in African HIV-1serodiscordant couples. AIDS 24, 737-744. Bailey, R.C., Moses, S., Parker, C.B., Agot, K., Maclean, I., Krieger, J.N., Williams, C.F., Campbell, R.T. & Ndinya-Achola, J.O. (2007). Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369, 643-656. Bailey, R.C., Moses, S., Parker, C.B., Agot, K., Maclean, I., Krieger, J.N., Williams, C.F. & Ndinya-Achola, J.O. (2008). The protective effect of male circumcision is sustained for at least 42 months: results from the Kisumu, Kenya Trial. XVII International AIDS Conference, 2008, THAC05. Bailey, R.C. & Mehta, S.D. (2009). Circumcision's place in the vicious cycle involving herpes simplex virus type 2 and HIV. J Infect Dis 199, 923-925. Bailey, R.C., S. Moses, S., C.B. Parker, C.B., Agot, K., MacLean, I., Krieger, J.N., Williams, C.F.M. & Ndinya-Achola, J.O. (2010). The protective effect of adult male circumcision against HIV acquisition is sustained for at least 54 months: results from the Kisumu, Kenya trial. XVIII International AIDS Confernece, Jul 18-23, 2010, Vienna, Abstract#FRLBC1. Balkan, C., Karapinar, D., Aydogdu, S., Ozcan, C., Ay, Y., Akin, M. & Kavakli, K. (2010). Surgery in patients with haemophilia and high responding inhibi<strong>to</strong>rs: Izmir experience. Haemophilia 16, 902-909. Barone, M.A., Ndede, F., Li, P.S., Masson, P., Awori, Q., Okech, J., Cherutich, P., Muraguri, N., Perchal, P., Lee, R., Kim, H.H. & Goldstein, M. (2011). The Shang Ring device for adult male circumcision: A proof of concept study in Kenya. J Acquir Immune Defic Syndr., Feb 21 [Epub ahead of print]. Ben Chaim, J., Livne, P.M., Binyamini, J., Hardak, B., Ben-Meir, D. & Mor, Y. (2005). Complications of circumcision in Israel: a one year multicenter survey. Isr Med Assoc J 7, 368-370. Ben, K.L., Xu, J.C., Lu, L., Lü, N.Q., Cheng, Y., Tao, J., Liu, D.K., Min, X.D., Cao, X.M. & Li, P.S. (2009). [Male circumcision is an effective "surgical vaccine" for HIV prevention and reproductive health](in Chinese). Zhonghua Nan Ke Xue 15, 395-402. Bode, C.O., Ikhisemojie, S. & Ademuyiwa, A.O. (2010). Penile injuries from proximal migration of the plastibell circumcision ring. J Pediatr Urol 6, 23-27 Boggiano, C. & Littman, D.R. (2007). HIV's vagina travelogue. Immunity 26, 145-147. Bronstein, H. (1955). United States Patent US2747576 (Mogen clamp). (Priority date Feb 3,1955). Caballero-Hoyos, R. & Villasenor-Sierra, A. (2001). [Socioeconomic strata as a predic<strong>to</strong>r fac<strong>to</strong>r for constant condom use among adolescents] (Spanish). Rev Saude Publica 35, 531-538.
Male Circumcision: An Appraisal of Current Instrumentation Cameron, B.E., Simonsen, J.N., D'Costa, L.J., Ronald, A.R., Maitha, G.M., Gakinya, M.N., Cheang, M., Dinya-Achola, J.O., Piot, P., Brunham, R.C. & Plummer, F.A. (1989). Female <strong>to</strong> male transmission of human immunodeficiency virus type 1: risk fac<strong>to</strong>rs for seroconversion in men. Lancet ii, 403-407. Cathcart, P., Nuttall, M., van der Meulen, J., Ember<strong>to</strong>n, M. & Kenny, S.E. (2006). Trends in paediatric circumcision and its complications in England between 1997 and 2003. Br J Surg 93, 885-890. Chekmarev, V.M. (1989). Union of Soviet Socialist Republics Patent SU1683702 (Laser Shield; Uzbek). (Priority date Jul 19,1989). Cheng, D., Hurt, L. & Horon, I.L. (2008). Neonatal circumcision in Maryland: a comparison of hospital discharge and maternal postpartum survey data. J Pediatr Urol 4, 448- 451. Cheng, W. & Saing, H. (1997). A prospective randomized study of wound approximation with tissue glue in circumcision in children. J Paediatr Child Health 33, 515-516. Cheng, Y., Peng, Y.F., Liu, Y.D., Tian, L., Lü, N.Q., Su, X.J., Yan, Z.J., Hu, J.S., Lee, R., Kim, H.H., Sokal, D.C. & Li, P.S. (2009). [A recommendable standard pro<strong>to</strong>col of adult male circumcision with the Chinese Shang Ring: outcomes of 328 cases in China] [Article in Chinese]. Zhonghua Nan Ke Xue 15, 584-592. Christakis, D.A., Harvey, E., Zerr, D.M., Feudtner, C., Wright, J.A. & Connell, F.A. (2000). A trade-off analysis of routine newborn circumcision. Pediatrics 105, 246-249. Cilen<strong>to</strong>, B.G.J., Holmes, N.M. & Canning, D.A. (1999). Plastibell complications revisited. Clin Pediatr 38, 239-242. Coates, T.J., Richter, L. & Caceres, C. (2008). Behavioural strategies <strong>to</strong> reduce HIV transmission: how <strong>to</strong> make them work better. Lancet 372, 669-684. Cohen, B. (2002). United States Patent US7080984 (Circumcision training aid). (Priority date Apr 29, 2002). Cooper, D.A., Wodak, A.D. & Morris, B.J. (2010). The case for boosting infant male circumcision in the face of rising heterosexual transmission of HIV. Med J Aust 193, 318-319. D'Arcy, F.T. & Jaffry, S.Q. (2011). A review of 100 consecutive sutureless child and adult circumcisions. Ir J Med Sci 180, 51-53. de Witte, L., Naba<strong>to</strong>v, A., Pion, M., Fluitsma, D., de Jong, M.A., de Gruijl, T., Piguet, V., van Kooyk, Y. & Geijtenbeek, T.B. (2007). Langerin is a natural barrier <strong>to</strong> HIV-1 transmission by Langerhans cells. Nat Med 13, 367-371. Decastro, B., Gurski, J. & Peterson, A. (2010). Adult template circumcision: a prospective, randomized, patient-blinded, comparative study evaluating the safety and efficacy of a novel circumcision device. Urology 76, 810-814. Donovan, B. & Ross, M.W. (2000). Preventing HIV: determinants of sexual behaviour (review). Lancet 355, 1897-1901. Duncan, N.D., Dundas, S.E., Brown, B., Pinnock-Ramsaran, C. & Badal, G. (2004). Newborn circumcision using the Plastibell device: an audit of practice. West Indian Med J 53, 23-26. Elder, J.S. (2007). Surgery illustrated: circumcision. BJU Int 99, 1553-1564. Elemen, L., Seyidov, T.H. & Tugay, M. (2010). The advantages of cyanoacrylate wound closure in circumcision. Pediatr Surg Int, Oct 13 [Epub ahead of print]. 345
- Page 1 and 2:
BIOMEDICAL ENGINEERING - FROM THEOR
- Page 3:
free online editions of InTech Book
- Page 6:
VI Contents Chapter 9 Targeted Magn
- Page 10:
X Preface stand-alone and readers c
- Page 14 and 15:
2 Biomedical Engineering - From The
- Page 16 and 17:
4 Fig. 2. Process for retrieval inf
- Page 18 and 19:
6 Biomedical search engine Scientif
- Page 20 and 21:
8 Biomedical Engineering - From The
- Page 22 and 23:
10 Biomedical Engineering - From Th
- Page 24 and 25:
12 Bireme http://regional.bv salud.
- Page 26 and 27:
14 Semantic Networks analysis Biome
- Page 28 and 29:
16 Biomedical Engineering - From Th
- Page 30 and 31:
18 Biomedical Engineering - From Th
- Page 32 and 33:
20 Biomedical Engineering - From Th
- Page 34 and 35:
22 Biomedical Engineering - From Th
- Page 36 and 37:
24 Biomedical Engineering - From Th
- Page 38 and 39:
26 Biomedical Engineering - From Th
- Page 40 and 41:
28 Biomedical Engineering - From Th
- Page 42 and 43:
30 Biomedical Engineering - From Th
- Page 44 and 45:
32 Biomedical Engineering - From Th
- Page 46 and 47:
34 Biomedical Engineering - From Th
- Page 48 and 49:
36 Biomedical Engineering - From Th
- Page 50 and 51:
38 Biomedical Engineering - From Th
- Page 52 and 53:
40 Biomedical Engineering - From Th
- Page 54 and 55:
42 Biomedical Engineering - From Th
- Page 56 and 57:
44 Biomedical Engineering - From Th
- Page 58 and 59:
46 Biomedical Engineering - From Th
- Page 60 and 61:
48 Biomedical Engineering - From Th
- Page 62 and 63:
50 Biomedical Engineering - From Th
- Page 64 and 65:
52 Biomedical Engineering - From Th
- Page 66 and 67:
54 Biomedical Engineering - From Th
- Page 68 and 69:
56 Biomedical Engineering - From Th
- Page 70 and 71:
58 Biomedical Engineering - From Th
- Page 72 and 73:
60 Biomedical Engineering - From Th
- Page 74 and 75:
62 Biomedical Engineering - From Th
- Page 76 and 77:
64 Biomedical Engineering - From Th
- Page 78 and 79:
66 Biomedical Engineering - From Th
- Page 80 and 81:
68 Biomedical Engineering - From Th
- Page 82 and 83:
70 Biomedical Engineering - From Th
- Page 84 and 85:
72 Biomedical Engineering - From Th
- Page 86 and 87:
74 Biomedical Engineering - From Th
- Page 88 and 89:
76 Biomedical Engineering - From Th
- Page 90 and 91:
78 Biomedical Engineering - From Th
- Page 92 and 93:
80 Biomedical Engineering - From Th
- Page 94 and 95:
82 Biomedical Engineering - From Th
- Page 96 and 97:
84 Biomedical Engineering - From Th
- Page 98 and 99:
86 Biomedical Engineering - From Th
- Page 100 and 101:
88 Biomedical Engineering - From Th
- Page 102 and 103:
90 Biomedical Engineering - From Th
- Page 104 and 105:
92 Biomedical Engineering - From Th
- Page 106 and 107:
94 Biomedical Engineering - From Th
- Page 108 and 109:
96 Biomedical Engineering - From Th
- Page 110 and 111:
98 Biomedical Engineering - From Th
- Page 112 and 113:
100 Biomedical Engineering - From T
- Page 114 and 115:
102 Biomedical Engineering - From T
- Page 116 and 117:
104 Biomedical Engineering - From T
- Page 118 and 119:
106 Biomedical Engineering - From T
- Page 120 and 121:
108 Method (Detection) CIEF-tITP-CZ
- Page 122 and 123:
110 Method (Detection) Analyte Matr
- Page 124 and 125:
112 Biomedical Engineering - From T
- Page 126 and 127:
114 Biomedical Engineering - From T
- Page 128 and 129:
116 Biomedical Engineering - From T
- Page 130 and 131:
118 Biomedical Engineering - From T
- Page 132 and 133:
120 6. Conclusion Biomedical Engine
- Page 134 and 135:
122 Biomedical Engineering - From T
- Page 136 and 137:
124 Biomedical Engineering - From T
- Page 138 and 139:
126 Biomedical Engineering - From T
- Page 140 and 141:
128 Biomedical Engineering - From T
- Page 142 and 143:
130 Biomedical Engineering - From T
- Page 144 and 145:
132 Biomedical Engineering - From T
- Page 146 and 147:
134 Biomedical Engineering - From T
- Page 148 and 149:
136 Biomedical Engineering - From T
- Page 150 and 151:
138 Biomedical Engineering - From T
- Page 152 and 153:
140 Biomedical Engineering - From T
- Page 154 and 155:
142 Biomedical Engineering - From T
- Page 156 and 157:
144 Biomedical Engineering - From T
- Page 158 and 159:
146 Biomedical Engineering - From T
- Page 160 and 161:
148 Biomedical Engineering - From T
- Page 162 and 163:
150 5. Conclusions Biomedical Engin
- Page 164 and 165:
152 Biomedical Engineering - From T
- Page 166 and 167:
154 Biomedical Engineering - From T
- Page 168 and 169:
156 Biomedical Engineering - From T
- Page 170 and 171:
158 Biomedical Engineering - From T
- Page 172 and 173:
160 Biomedical Engineering - From T
- Page 174 and 175:
162 1 st phase : half year 4 2 nd p
- Page 176 and 177:
164 Biomedical Engineering - From T
- Page 178 and 179:
166 7. Innovative active training B
- Page 180 and 181:
168 Biomedical Engineering - From T
- Page 182 and 183:
170 Biomedical Engineering - From T
- Page 184 and 185:
172 12. Maturing projects’ story
- Page 186 and 187:
174 Biomedical Engineering - From T
- Page 188 and 189:
176 Biomedical Engineering - From T
- Page 190 and 191:
178 Biomedical Engineering - From T
- Page 192 and 193:
180 16. Acknowledgments Biomedical
- Page 194 and 195:
182 Biomedical Engineering - From T
- Page 196 and 197:
184 Biomedical Engineering - From T
- Page 198 and 199:
186 Biomedical Engineering - From T
- Page 200 and 201:
188 Biomedical Engineering - From T
- Page 202 and 203:
190 R* M M M M MR*M O O O O M O R*
- Page 204 and 205:
192 Biomedical Engineering - From T
- Page 206 and 207:
194 Biomedical Engineering - From T
- Page 208 and 209:
196 Fig. 9. Chemical structure of 5
- Page 210 and 211:
198 Relative Intensity (AU) Biomedi
- Page 212 and 213:
200 Biomedical Engineering - From T
- Page 214 and 215:
202 Biomedical Engineering - From T
- Page 216 and 217:
204 2. Preparation of IO nanopartic
- Page 218 and 219:
206 Biomedical Engineering - From T
- Page 220 and 221:
208 Biomedical Engineering - From T
- Page 222 and 223:
210 Biomedical Engineering - From T
- Page 224 and 225:
212 Biomedical Engineering - From T
- Page 226 and 227:
214 Biomedical Engineering - From T
- Page 228 and 229:
216 Biomedical Engineering - From T
- Page 230 and 231:
218 Biomedical Engineering - From T
- Page 232 and 233:
220 Biomedical Engineering - From T
- Page 234 and 235:
222 Biomedical Engineering - From T
- Page 236 and 237:
224 Biomedical Engineering - From T
- Page 238 and 239:
226 Biomedical Engineering - From T
- Page 240 and 241:
228 Biomedical Engineering - From T
- Page 242 and 243:
230 Biomedical Engineering - From T
- Page 244 and 245:
232 Biomedical Engineering - From T
- Page 246 and 247:
234 Biomedical Engineering - From T
- Page 248 and 249:
236 Biomedical Engineering - From T
- Page 250 and 251:
238 Biomedical Engineering - From T
- Page 252 and 253:
240 Biomedical Engineering - From T
- Page 254 and 255:
242 Biomedical Engineering - From T
- Page 256 and 257:
244 Biomedical Engineering - From T
- Page 258 and 259:
246 Biomedical Engineering - From T
- Page 260 and 261:
248 Biomedical Engineering - From T
- Page 262 and 263:
250 Biomedical Engineering - From T
- Page 264 and 265:
252 Biomedical Engineering - From T
- Page 266 and 267:
254 Biomedical Engineering - From T
- Page 268 and 269:
256 3. Deposition techniques Biomed
- Page 270 and 271:
258 Biomedical Engineering - From T
- Page 272 and 273:
260 Biomedical Engineering - From T
- Page 274 and 275:
262 Biomedical Engineering - From T
- Page 276 and 277:
264 Biomedical Engineering - From T
- Page 278 and 279:
266 Biomedical Engineering - From T
- Page 280 and 281:
268 Biomedical Engineering - From T
- Page 282 and 283:
270 Biomedical Engineering - From T
- Page 284 and 285:
272 Biomedical Engineering - From T
- Page 286 and 287:
274 Biomedical Engineering - From T
- Page 288 and 289:
276 Biomedical Engineering - From T
- Page 290 and 291:
278 Biomedical Engineering - From T
- Page 292 and 293:
280 Biomedical Engineering - From T
- Page 294 and 295:
282 Biomedical Engineering - From T
- Page 296 and 297:
284 Biomedical Engineering - From T
- Page 298 and 299:
286 Biomedical Engineering - From T
- Page 300 and 301:
288 Biomedical Engineering - From T
- Page 302 and 303:
290 Biomedical Engineering - From T
- Page 304 and 305:
292 Biomedical Engineering - From T
- Page 306 and 307: 294 Biomedical Engineering - From T
- Page 308 and 309: 296 Biomedical Engineering - From T
- Page 310 and 311: 298 Biomedical Engineering - From T
- Page 312 and 313: 300 2. Nanoparticles in biomedical
- Page 314 and 315: 302 Biomedical Engineering - From T
- Page 316 and 317: 304 Biomedical Engineering - From T
- Page 318 and 319: 306 Biomedical Engineering - From T
- Page 320 and 321: 308 Biomedical Engineering - From T
- Page 322 and 323: 310 Biomedical Engineering - From T
- Page 324 and 325: 312 Biomedical Engineering - From T
- Page 326 and 327: 314 Biomedical Engineering - From T
- Page 328 and 329: 316 Biomedical Engineering - From T
- Page 330 and 331: 318 Biomedical Engineering - From T
- Page 332 and 333: 320 Biomedical Engineering - From T
- Page 334 and 335: 322 Biomedical Engineering - From T
- Page 336 and 337: 324 Biomedical Engineering - From T
- Page 338 and 339: 326 Biomedical Engineering - From T
- Page 340 and 341: 328 Biomedical Engineering - From T
- Page 342 and 343: 330 Biomedical Engineering - From T
- Page 344 and 345: 332 Biomedical Engineering - From T
- Page 346 and 347: 334 Biomedical Engineering - From T
- Page 348 and 349: 336 Biomedical Engineering - From T
- Page 350 and 351: 338 Biomedical Engineering - From T
- Page 352 and 353: 340 Biomedical Engineering - From T
- Page 354 and 355: 342 Biomedical Engineering - From T
- Page 358 and 359: 346 Biomedical Engineering - From T
- Page 360 and 361: 348 Biomedical Engineering - From T
- Page 362 and 363: 350 Biomedical Engineering - From T
- Page 364 and 365: 352 Biomedical Engineering - From T
- Page 366 and 367: 354 Biomedical Engineering - From T
- Page 368 and 369: 356 Biomedical Engineering - From T
- Page 370 and 371: 358 Biomedical Engineering - From T
- Page 372 and 373: 360 Biomedical Engineering - From T
- Page 374 and 375: 362 Biomedical Engineering - From T
- Page 376 and 377: 364 Biomedical Engineering - From T
- Page 378 and 379: 366 Biomedical Engineering - From T
- Page 380 and 381: 368 Biomedical Engineering - From T
- Page 382 and 383: 370 Biomedical Engineering - From T
- Page 384 and 385: 372 Biomedical Engineering - From T
- Page 386 and 387: 374 Biomedical Engineering - From T
- Page 388 and 389: 376 Biomedical Engineering - From T
- Page 390 and 391: 378 Biomedical Engineering - From T
- Page 392 and 393: 380 Biomedical Engineering - From T
- Page 394 and 395: 382 Biomedical Engineering - From T
- Page 396 and 397: 384 Biomedical Engineering - From T
- Page 398 and 399: 386 Biomedical Engineering - From T
- Page 400 and 401: 388 Biomedical Engineering - From T
- Page 402 and 403: 390 Biomedical Engineering - From T
- Page 404 and 405: 392 Biomedical Engineering - From T
- Page 406 and 407:
394 Biomedical Engineering - From T
- Page 408 and 409:
396 Biomedical Engineering - From T
- Page 410 and 411:
398 Biomedical Engineering - From T
- Page 412 and 413:
400 Biomedical Engineering - From T
- Page 414 and 415:
402 Biomedical Engineering - From T
- Page 416 and 417:
404 Biomedical Engineering - From T
- Page 418 and 419:
406 Biomedical Engineering - From T
- Page 420 and 421:
408 Biomedical Engineering - From T
- Page 422 and 423:
410 Biomedical Engineering - From T
- Page 424 and 425:
412 Biomedical Engineering - From T
- Page 426 and 427:
414 Biomedical Engineering - From T
- Page 428 and 429:
416 Biomedical Engineering - From T
- Page 430 and 431:
418 Biomedical Engineering - From T
- Page 432 and 433:
420 Biomedical Engineering - From T
- Page 434 and 435:
422 Biomedical Engineering - From T
- Page 436 and 437:
424 Biomedical Engineering - From T
- Page 438 and 439:
426 Biomedical Engineering - From T
- Page 440 and 441:
428 Biomedical Engineering - From T
- Page 442 and 443:
430 Biomedical Engineering - From T
- Page 444 and 445:
432 Biomedical Engineering - From T
- Page 446 and 447:
434 3. Three dimensional virtual mo
- Page 448 and 449:
436 Biomedical Engineering - From T
- Page 450 and 451:
438 Biomedical Engineering - From T
- Page 452 and 453:
440 Biomedical Engineering - From T
- Page 454 and 455:
442 Biomedical Engineering - From T
- Page 456 and 457:
444 Biomedical Engineering - From T
- Page 458 and 459:
446 Biomedical Engineering - From T
- Page 460 and 461:
448 Biomedical Engineering - From T
- Page 462 and 463:
450 Biomedical Engineering - From T
- Page 464 and 465:
452 Biomedical Engineering - From T
- Page 466 and 467:
454 In this case, the eigenvalues a
- Page 468 and 469:
456 where Biomedical Engineering -
- Page 470 and 471:
458 Biomedical Engineering - From T
- Page 472 and 473:
460 Biomedical Engineering - From T
- Page 474 and 475:
462 Biomedical Engineering - From T
- Page 476 and 477:
464 Biomedical Engineering - From T
- Page 478 and 479:
466 Biomedical Engineering - From T
- Page 480 and 481:
468 Biomedical Engineering - From T
- Page 482 and 483:
470 Biomedical Engineering - From T
- Page 484 and 485:
472 Nb b b l l1 Biomedical Engineer
- Page 486 and 487:
474 Biomedical Engineering - From T
- Page 488 and 489:
476 Biomedical Engineering - From T
- Page 490 and 491:
478 Load F (μN) Parallel-oriented
- Page 492 and 493:
480 Biomedical Engineering - From T
- Page 494 and 495:
482 Biomedical Engineering - From T
- Page 496 and 497:
484 Biomedical Engineering - From T
- Page 498:
486 Biomedical Engineering - From T